Weight Loss Care in Maryland
The History of BMI: From Social Physics to a Modern Health Tool
The Body Mass Index (BMI) is one of healthcare’s most widely used tools. Doctors, researchers, and policymakers rely on it to assess weight, track health risks, and develop public health strategies. It’s simple, universal, and easy to calculate. But have you ever wondered where it came from? How did a mathematical formula turn into the global standard for measuring body weight?
Published
Can Obesity Cause Cancer? Understanding the Types and Risks
Keeping a healthy weight is essential for long-term wellness. Extra weight doesn’t just affect appearance—it significantly raises the risk of diseases, including cancer. Obesity, defined by excessive body fat, goes beyond aesthetic concerns and plays a role in making the body more susceptible to certain cancers.
Published
Retatrutide: A Promising Breakthrough for Fatty Liver Disease
Fatty liver disease has become a global health crisis, affecting millions worldwide. Now called metabolic dysfunction-associated steatotic liver disease (MASLD), its prevalence has skyrocketed due to rising obesity rates. Retatrutide, a triple hormone receptor agonist, is showing a game-changing potential in reducing liver fat and improving metabolic health.
Published
History of GLP-1: From Discovery to Revolutionary Treatment
The discovery of GLP-1 transformed diabetes treatment and opened possibilities for addressing other health challenges. What began as a search for proglucagon-derived peptides led to groundbreaking drugs. GLP-1’s journey showcases the impact of scientific breakthroughs.
Published
Categorized as Diabetes Care, Dr. Tashko’s History Notes, GLP1 agonist, Insights from Dr. Tashko, Physiology, Weight Loss
Tirzepatide: A Double Approach to Diabetes and Weight Loss
Tirzepatide is a groundbreaking therapy gaining attention for treating type 2 diabetes and obesity. Unlike traditional drugs that target one pathway, tirzepatide uses two hormones, GLP-1 and GIP, to achieve a fuller metabolic control.
Published
Categorized as Diabetes Care, GLP1 agonist, Insights from Dr. Tashko, Tirzepatide Patient Information, Weight Loss
Muscle Loss and GLP-1 Agonists: What You Need to Know
While GLP-1 agonists offer exciting potential, some patients worry about their effects on muscle mass during weight loss. Let’s break down what’s happening in the body when using these medications, and how to protect your muscles.
Published
Categorized as GLP1 agonist, Insights from Dr. Tashko, Insulin Resistance, Muscle Physiology, Weight Loss